These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 565169)

  • 1. Blood clot formation during multiple cardiopulmonary bypass procedures necessitated by massive hemorrhage.
    King DO; Kane PB
    Anesth Analg; 1978; 57(2):273-6. PubMed ID: 565169
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of viscoelastic coagulation tests during cardiopulmonary bypass.
    Ortmann E; Rubino A; Altemimi B; Collier T; Besser MW; Klein AA
    J Thromb Haemost; 2015 Jul; 13(7):1207-16. PubMed ID: 25903995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Con: Heparin-bonded cardiopulmonary bypass circuits should be routine for all cardiac surgical procedures.
    Taneja R; Cheng DC
    Anesth Analg; 2006 Dec; 103(6):1370-2. PubMed ID: 17122205
    [No Abstract]   [Full Text] [Related]  

  • 4. Massive intracavitary clot formation during cardiopulmonary bypass.
    Legare JF; Arora R; Wood JW
    Can J Cardiol; 2004 Jun; 20(8):825-6. PubMed ID: 15229767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracardiac thrombus: a risk of incomplete anticoagulation for cardiac operations.
    Cheung AT; Levin SK; Weiss SJ; Acker MA; Stenach N
    Ann Thorac Surg; 1994 Aug; 58(2):541-2. PubMed ID: 8067860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery.
    Babka R; Colby C; El-Etr A; Pifarré R
    J Thorac Cardiovasc Surg; 1977 May; 73(5):780-2. PubMed ID: 850438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Sonoclot hemostasis analysis after cardiopulmonary bypass on postoperative hemorrhage in cardiac surgery.
    Yamada T; Katori N; Tanaka KA; Takeda J
    J Anesth; 2007; 21(2):148-52. PubMed ID: 17458642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive Strategies for Minimizing Hemodilution in the Cardiac Surgery Patient During Cardiopulmonary Bypass.
    Hwang NC
    J Cardiothorac Vasc Anesth; 2015 Dec; 29(6):1663-71. PubMed ID: 26520025
    [No Abstract]   [Full Text] [Related]  

  • 9. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of fresh blood to control severe haemorrhage associated with massive blood transfusion after cardiopulmonary bypass.
    Macfie A; Goiti J; Hunsley J
    Eur J Cardiothorac Surg; 1990; 4(3):171-3. PubMed ID: 2334557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of low vs conventional-dose heparin for minimal cardiopulmonary bypass in coronary artery bypass grafting surgery.
    Fromes Y; Daghildjian K; Caumartin L; Fischer M; Rouquette I; Deleuze P; Bical OM
    Anaesthesia; 2011 Jun; 66(6):488-92. PubMed ID: 21501130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extreme Plasma Dilution Decreases Heparin and Protamine Cardiopulmonary Bypass Requirements: A Case Report on a Jehovah's Witness Patient.
    Chang E; Gatling JW; Bode S; Herrmann PC; Bull BS; Applegate RL
    A A Case Rep; 2017 Jun; 8(11):291-293. PubMed ID: 28328588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Platelet Count and Postoperative Blood Loss in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass and Fresh Frozen Plasma Administration Guided by Thromboelastometry.
    Ichikawa J; Osada Y; Kodaka M; Nishiyama K; Komori M
    Circ J; 2018 Feb; 82(3):677-683. PubMed ID: 29238008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
    Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
    Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated clotting time during cardiopulmonary bypass: is repetition necessary during open heart surgery?
    Neema PK; Sinha PK; Rathod RC
    Asian Cardiovasc Thorac Ann; 2004 Mar; 12(1):47-52. PubMed ID: 14977742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of activated coagulation time to monitor heparin during cardiac surgery.
    Roth JA; Cukingnan RA; Scott CR
    Ann Thorac Surg; 1979 Jul; 28(1):69-72. PubMed ID: 454047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiopulmonary bypass strategy with low-dose heparin and nafamostat mesilate in cardiac surgery: a safe option for patients with acute stroke.
    Morimoto N; Henmi S; Yoshida M; Mukohara N
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):726-8. PubMed ID: 22541513
    [No Abstract]   [Full Text] [Related]  

  • 18. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro: Heparin-coated circuits should be used for cardiopulmonary bypass.
    Jessen ME
    Anesth Analg; 2006 Dec; 103(6):1365-9. PubMed ID: 17122204
    [No Abstract]   [Full Text] [Related]  

  • 20. Reoperative sternotomy: minimizing injury without the risks of systemic heparin.
    Singh AK; Stearns G; Maslow A; Feng WC; Schwartz C
    J Thorac Cardiovasc Surg; 2011 Apr; 141(4):1085; author reply 1085. PubMed ID: 21419908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.